Literature DB >> 15145940

Critical amino acid residues in transmembrane domain 1 of the human organic anion transporter hOAT1.

Mei Hong1, Fanfan Zhou, Guofeng You.   

Abstract

Human organic anion transporter 1 (hOAT1) belongs to a superfamily of organic anion transporters, which play critical roles in the body disposition of clinically important drugs, including anti-human immunodeficiency virus therapeutics, anti-tumor drugs, antibiotics, anti-hypertensives, and anti-inflammatories. Previously we suggested that the predicted transmembrane domain 1 (TM1) of hOAT1 might be important for its function. In the present study, we examined the role of each residue within TM1 of hOAT1 in substrate recognition and transport. Alanine scanning was used to construct mutants of hOAT1, and the uptake of model substrate para-aminohippurate was studied in COS-7 cells expressing the mutant transporters. This approach led to the discovery of two critical amino acid residues, Leu-30 and Thr-36. A substitution of Leu-30 or Thr-36 with alanine resulted in a complete loss of transport activities. We then further characterized Leu-30 and Thr-36 by mutagenizing these residues to amino acids with different physicochemical properties. Leu-30 was replaced with amino acids with varying sizes of side chains, including glycine, valine, and isoleucine. We showed that progressively smaller side chains at position 30 increasingly impaired hOAT1 function mainly because of the impaired surface expression of the transporter. Thr-36, another critical amino acid in TM1, was replaced by serine and cysteine. Similar to the substitution of Thr-36 by alanine, substitution by serine and cysteine at this position abolished transport activity without affecting the surface expression of the transporter. The fact that Thr-36 cannot be substituted with serine and that the side chains of alanine, serine, and cysteine are smaller than that of threonine by a methyl group indicate that both the methyl group and the hydroxyl group of Thr-36 could be critical for hOAT1 activity. Together we conclude that Leu-30 and Thr-36 play distinct roles in hOAT1 function. Leu-30 is important in targeting the transporter to the plasma membrane. In contrast, Thr-36 is critical for substrate recognition. The present study provided the first molecular evidence that transmembrane domain 1 is a critical determinant of hOAT1 function and may provide important insights into the structure-function relationships of the organic anion transporter family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15145940     DOI: 10.1074/jbc.M404686200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins.

Authors:  Xiaoxi Lu; Ting Chan; Chenghao Xu; Ling Zhu; Qi Tony Zhou; Kade D Roberts; Hak-Kim Chan; Jian Li; Fanfan Zhou
Journal:  J Antimicrob Chemother       Date:  2015-10-22       Impact factor: 5.790

Review 3.  Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles.

Authors:  Ahsan N Rizwan; Gerhard Burckhardt
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

Review 4.  Physiology, structure, and regulation of the cloned organic anion transporters.

Authors:  C Srimaroeng; J L Perry; J B Pritchard
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

5.  Potent inhibitors of human organic anion transporters 1 and 3 from clinical drug libraries: discovery and molecular characterization.

Authors:  Peng Duan; Shanshan Li; Ni Ai; Longqin Hu; William J Welsh; Guofeng You
Journal:  Mol Pharm       Date:  2012-09-25       Impact factor: 4.939

6.  Functional characterization of nonsynonymous single nucleotide polymorphisms in the human organic anion transporter 4 (hOAT4).

Authors:  Fanfan Zhou; Ling Zhu; Pei H Cui; W Bret Church; Michael Murray
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

Review 7.  Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.

Authors:  Sun-Young Ahn; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2009-06-10       Impact factor: 4.436

8.  Novobiocin is a potent inhibitor for human organic anion transporters.

Authors:  Peng Duan; Guofeng You
Journal:  Drug Metab Dispos       Date:  2009-03-12       Impact factor: 3.922

9.  Regulation of human organic anion transporter 1 by ANG II: involvement of protein kinase Calpha.

Authors:  Shanshan Li; Peng Duan; Guofeng You
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-16       Impact factor: 4.310

10.  Putative transmembrane domain 12 of the human organic anion transporter hOAT1 determines transporter stability and maturation efficiency.

Authors:  Mei Hong; Shanshan Li; Fanfan Zhou; Paul E Thomas; Guofeng You
Journal:  J Pharmacol Exp Ther       Date:  2009-11-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.